We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Accurate Classification System for Patients With COVID-19 Pneumonitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04302688
Recruitment Status : Completed
First Posted : March 10, 2020
Last Update Posted : March 10, 2020
Information provided by (Responsible Party):
Gong Qiong, Renmin Hospital of Wuhan University

Brief Summary:
The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.

Condition or disease

Detailed Description:
  1. First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group.
  2. Responsible for the risk factor of regression equation according to the model. The patients were divided into three groups according to their total score of risk responsibility.
  3. Compared with SEPSIS and CURB-65 grading system with the grading system we established.

Layout table for study information
Study Type : Observational
Actual Enrollment : 669 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: Accurate Classification System for Patients With COVID-19 Based on Prognostic Nomogram
Actual Study Start Date : December 10, 2019
Actual Primary Completion Date : February 10, 2020
Actual Study Completion Date : March 4, 2020

Resource links provided by the National Library of Medicine

modeling cohort
The 445 patients were grouped in chronological order.
validating colort
The remaining 224 patients.

Primary Outcome Measures :
  1. survival status [ Time Frame: 10 December 2019 to 10 February 2020 ]
    survival status as of February 24, 2020

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with novel coronavirus pneumonia, and all cases were collected from the People's Hospital of Wuhan University.

Inclusion Criteria:

  • Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid.

Exclusion Criteria:

  • Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia.
  • Suspected patient review refers to the negative nucleic acid test.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04302688

Layout table for location information
China, Hubei
Renmin Hospital of Wuhan University
Wuhan, Hubei, China, 430060
Sponsors and Collaborators
Renmin Hospital of Wuhan University
Layout table for investigator information
Principal Investigator: Qiong Gong, MD. Renmin Hospital of Wuhan University
Layout table for additonal information
Responsible Party: Gong Qiong, Professor, Renmin Hospital of Wuhan University
ClinicalTrials.gov Identifier: NCT04302688    
Other Study ID Numbers: COVID-19 WU1
First Posted: March 10, 2020    Key Record Dates
Last Update Posted: March 10, 2020
Last Verified: March 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Not going to share for the time being.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Respiratory Tract Infections
Lung Diseases
Respiratory Tract Diseases